Ginkgo Bioworks

Ginkgo Bioworks is a synthetic biology company. They went public on the NYSE on Sept 17, 2021, under the ticker symbol ‘DNA’. Ginkgo designs microorganisms for producing materials and medicines, waste treatment, and other applications.

Would you like to explore more?

With a Mergeflow account, you can explore technologies, companies, R&D and markets—beyond the example above.

Try it out yourself:

No credit card, no software to install. Trial ends automatically after 14 days.

See how Mergeflow works

Watch our free video course:

Teams and individuals from across industries and tech sectors use Mergeflow